XEL logo

XEL

Xcel Energy Inc.

$81.14
+$0.06(+0.07%)
70
Overall
100
Value
66
Tech
44
Quality
How is this score calculated?
Market Cap
$47.47B
Volume
1.80M
52W Range
$65.21 - $84.23
Target Price
$92.22

Company Overview

Mkt Cap$47.47BPrice$81.14
Volume1.80MChange+0.07%
P/E Ratio23.5Open$81.21
Revenue$2.5BPrev Close$81.08
Net Income$2.0B52W Range$65.21 - $84.23
Div Yield2.37%Target$92.22
Overall70Value100
Quality44Technical66

No chart data available

About Xcel Energy Inc.

Xcel Energy Inc., through its subsidiaries, engages in the generation, purchasing, transmission, distribution, and sale of electricity in the United States. It operates through Regulated Electric Utility and Regulated Natural Gas Utility segments. The company generates electricity through wind, nuclear, hydroelectric, biomass, and solar energy sources, as well as coal, natural gas, oil, wood, and refuse-derived fuels. It also purchases, transports, distributes, and sells natural gas to retail customers, as well as transports customer-owned natural gas. In addition, the company develops and leases natural gas pipelines, and storage and compression facilities; and invests in rental housing projects and nonregulated assets, as well as procures equipment for the construction of renewable generation facilities. It serves residential, commercial, and industrial customers in the portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. Xcel Energy Inc. was formerly known as Northern States Power company. The company was incorporated in 1909 and is headquartered in Minneapolis, Minnesota.

Sector: Utilities
Industry: Utilities - Regulated Electric

Latest News

Xcel Energy Shareholders Back Board, Pay and Auditor

An update from Xcel Energy ( ($XEL) ) is now available. At Xcel Energy’s 2026 Annual Meeting of Shareholders held on May 20, 2026, investors electe...

TipRanks Auto-Generated Newsdesk4 days ago

Goldman Sachs Keeps Their Buy Rating on Xcel Energy (XEL)

TipRanks Auto-Generated Intelligence Newsdesk5 days ago

Exelixis Advances Zanzalintinib Into Phase 2 Meningioma Trial, Signaling Pipeline Expansion

TipRanks Clinical-Trials-Auto-Generated Newsdesk8 days ago

Exelixis Advances Zanzalintinib Into Phase 2 Meningioma Trial, Signaling Pipeline Expansion

TipRanks Clinical-Trials-Auto-Generated Newsdesk8 days ago

Noble Financial Sticks to Their Buy Rating for XCel Brands (XELB)

TipRanks Auto-Generated Intelligence Newsdesk11 days ago
ABCD
1SymbolPriceChangeVol
2XEL$81.14+0.1%1.80M
3
4
5
6

Get Xcel Energy Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.